Literature DB >> 25413656

Retarded tempo of physiological development in childhood delays the onset of the metabolic syndrome in adulthood.

Shumei S Sun1, Adam P Sima, John H Himes.   

Abstract

Using serial data from the Fels Longitudinal Study, we investigated the effects of early and late attainment of the peak height velocity (PHV) in childhood on the timing of the appearance of the metabolic syndrome later in life. We aimed to show if early attainment of PHV engenders greater risks for chronic diseases in boys than in girls. Therefore, we defined those boys and girls in sex-specific quartiles of the study population that were slowest to attain PHV as having a slow tempo of development, and those in the growth that most rapidly attained PHV as having a rapid tempo of development. Boys who experienced an early onset of PHV tended to have a higher risk for the metabolic syndrome, dyslipidemia and impaired fasting glucose than those who had late onset of PHV. Girls who had an early onset of PHV tended to develop more abdominal obesity than females who had a late onset of PHV.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 25413656      PMCID: PMC4309272          DOI: 10.1159/000365872

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  24 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

Review 2.  Linkage between insulin and the free radical theory of aging.

Authors:  David Julian; Christiaan Leeuwenburgh
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-01       Impact factor: 3.619

3.  Intima media thickness in childhood obesity: relations to inflammatory marker, glucose metabolism, and blood pressure.

Authors:  Thomas Reinehr; Wieland Kiess; Gideon de Sousa; Birgit Stoffel-Wagner; Ranier Wunsch
Journal:  Metabolism       Date:  2006-01       Impact factor: 8.694

4.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford; Wayne H Giles; William H Dietz
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

Review 5.  The effects of diet, overfeeding and moderate dietary restriction on Sprague-Dawley rat survival, disease and toxicology.

Authors:  K P Keenan; G C Ballam; R Dixit; K A Soper; P Laroque; B A Mattson; S P Adams; J B Coleman
Journal:  J Nutr       Date:  1997-05       Impact factor: 4.798

6.  Earlier onset of puberty in girls: relation to increased body mass index and race.

Authors:  P B Kaplowitz; E J Slora; R C Wasserman; S E Pedlow; M E Herman-Giddens
Journal:  Pediatrics       Date:  2001-08       Impact factor: 7.124

7.  Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study.

Authors:  G S Berenson; S R Srinivasan; W Bao; W P Newman; R E Tracy; W A Wattigney
Journal:  N Engl J Med       Date:  1998-06-04       Impact factor: 91.245

8.  Predictors of late menarche and adult height in children with anorexia nervosa.

Authors:  Catherine Rozé; Catherine Doyen; Marie-France Le Heuzey; Priscilla Armoogum; Marie-Christine Mouren; Juliane Léger
Journal:  Clin Endocrinol (Oxf)       Date:  2007-06-11       Impact factor: 3.478

9.  Prolonged juvenile States and delay of cardiovascular and metabolic risk factors: the Fels Longitudinal study.

Authors:  Shumei S Sun; Christine M Schubert
Journal:  J Pediatr       Date:  2009-09       Impact factor: 4.406

Review 10.  Exercise-induced endocrine pathologies.

Authors:  M P Warren; L R Goodman
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

View more
  1 in total

1.  Importance of characterizing growth trajectories.

Authors:  Nolwenn Regnault; Matthew W Gillman
Journal:  Ann Nutr Metab       Date:  2014-11-18       Impact factor: 3.374

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.